Key metabolic pathway implicated in intractable form of breast cancer
Monday, July 18, 2011 - 16:00
in Health & Medicine
Using a new in vivo screening system, Whitehead Institute researchers have identified a protein in the serine biosynthesis pathway that is essential in estrogen receptor (ER)-negative breast cancera notoriously difficult disease to treat associated with low five-year survival rates.